This is a "connection" page, showing publications co-authored by Fred Crawford and John Lazarchick.
Tricuspid valve replacement and ventricular septal defect repair in a patient with Glanzmann thrombasthenia. J Thorac Cardiovasc Surg. 2010 May; 139(5):e114-5.
Administration of recombinant activated factor VII in the intensive care unit after complex cardiovascular surgery: clinical and economic outcomes. J Thorac Cardiovasc Surg. 2011 Jun; 141(6):1469-77.e2.
Use of recombinant activated factor VII concentrate to control postoperative hemorrhage in complex cardiovascular surgery. Ann Thorac Surg. 2008 May; 85(5):1669-76; discussion 1676-7.